1 Market Value and Patent Citations : A First Look Bronwyn H . Hall UC Berkeley , Oxford Univ . , and NBER ( joint work with Adam Jaffe and Manuel Trajtenberg ) May 18 , 2001 HJT - Oxford - May 2001 2 Introduction Question : how to value intangible knowledge assets ? One answer : relate measures of economic value ( profit , market value , consumer willingness - to - pay ) to measures of innovation ( R & D spending , patent counts , … ) Difficulties : ! R & D spending an input to innovation , not an output ! R & D not broken down by technology field ! Patents add very little additional info in the presence of R & D May 18 , 2001 HJT - Oxford - May 2001 3 Our Questions 1 . Do the number of cites received by patents help to explain “value” in the presence of a . Patent counts themselves b . R & D spending 2 . What is the timing ? Is current market value better explained by past cites received or future cites not yet received ? 3 . Are self - citations more or less valuable than other citations ? May 18 , 2001 HJT - Oxford - May 2001 4 Might citations be useful ? R & D capital is an important explanatory variable for market value ( in US and UK , R 2 ~ 0 . 25 ) . Patents also matter , but are much less important , add little in presence of R & D ( Griliches , Hall , Pakes 1987 ) . WHY ? Patent value distribution is very skew Citations have been used to proxy for spillovers and to describe research trajectories ( Jaffe , Trajtenberg , and Henderson 1993 , Ham 1998 , etc . ) . Limited evidence that they correspond to anything “economic . ” Correlations with firm market value can help to validate the use of citations in economic analysis . May 18 , 2001 HJT - Oxford - May 2001 5 Outline What are patent citations ? The context : previous research on innovation valuation ( very briefly ) How do we use citations ? ! Measurement and modeling issues Results Future research May 18 , 2001 HJT - Oxford - May 2001 6 What are patent citations ? Somewhat like Citations in a Research Paper : References to prior technology , either patents or other scientific literature on which the current patent builds or which it uses Some added by the USPTO examiner ( the “referee” ) Some added after the fact ( not used by inventor ) Some added to avoid infringement ( limit scope , defense against suits ) Some added for “teaching” ( like survey articles ) ( See Jaffe , Trajtenberg , Fogarty inventor survey , NBER ) 2 May 18 , 2001 HJT - Oxford - May 2001 7 May 18 , 2001 HJT - Oxford - May 2001 8 May 18 , 2001 HJT - Oxford - May 2001 9 May 18 , 2001 HJT - Oxford - May 2001 10 Some facts about citations Prior work finds more valuable patents are cited more . One quarter of patents receive no citations . 0 . 01 % receive more than one hundred citations . Lag distribution is skew to the left with a mode at about 3 . 5 years . Most cites happen by 10 years , but there can be long lags ( 30 years ) . Number included per patent has increased recently with advent of computerized search . May 18 , 2001 HJT - Oxford - May 2001 11 Figure 3 Citation Distribution 0 50000 100000 150000 200000 250000 300000 0 7 14 21 28 35 42 49 56 63 70 77 84 91 98 105 112 124 132 140 155 175 221 Citation Count through 1995 N u m b e r o f P a t e n t s Citation Distribution - More than 100 Citations 0 10 20 30 40 101 111 121 131 141 151 161 171 181 191 > 200 Citation Count through 1995 N u m b e r o f P a t e n t s May 18 , 2001 HJT - Oxford - May 2001 12 Early evidence using patent citations to predict value Trajtenberg ( 1990 ) - consumer welfare for CAT scanners and citations Klock and Shane ( 1995 ) - market value of citation weighted patents in semiconductors Austin ( 1993 ) - event studies on citation - weighted biotech patents 3 May 18 , 2001 HJT - Oxford - May 2001 13 Recent work on citation value Hirschey et al ( 1998 ) ; Lev et al ( 1998 ) - accounting - based work similar to ours . Sampat ( 1998 ) and Ziedonis ( 1998 ) - correlating university licensing revenue with citations . ( reverse regression ) Harhoff , Narin , Scherer , and Vopel ( 1997 ) - German inventions patented in the U . S . Expected discounted profits correlated with citations . Lanjouw and Schankerman ( 1997 ) – correlated with litigation probability . May 18 , 2001 HJT - Oxford - May 2001 14 Our data and variables Approximately 4000 U . S . manufacturing firms 1976 - 1995 . Variables : capital stock , leverage , sales or earnings growth , market value ( debt plus equity ) , innovation measures : ! R & D stock ! Patent stock ! Citation - weighted patent stock ( i . e . , Cite stock ) All stocks constructed with 15 % depreciation . Citations corrected for truncation . May 18 , 2001 HJT - Oxford - May 2001 15 Figure 2 Citation Counts before and after Truncation Correction 0 . 00 2 . 00 4 . 00 6 . 00 8 . 00 10 . 00 12 . 00 1966 1968 1970 1972 1974 1976 1978 1980 1982 1984 1986 1988 1990 1992 Year C i t a t i on s p e r P a t e n t Total Cites per Patent ( raw ) Total Cites per Patent ( corrected ) May 18 , 2001 HJT - Oxford - May 2001 16 Constructing knowledge stocks K t = ( 1 - δ ) K t - 1 + R t where K t = knowledge stock at end of period t R t = flow of R & D or patents during t δ = depreciation rate of K , usually = 15 % Note : if R grows at a constant rate g over time , K t ! R t / ( δ + g ) = > K t ! R t / ( 0 . 15 + 0 . 05 ) = 5R t in this sample = > Low coefficient on K or R may imply δ > > 0 . 15 May 18 , 2001 HJT - Oxford - May 2001 17 “Theory” How to choose a functional form for the value equation ? Ideal : model investment in tangible and knowledge ( intangible ) assets under uncertainty using a dynamic program for the firm . Yields a value function for the assets of the firm . Practice : use an ad hoc hedonic equation to price the assets ( generalized Tobin’s q approach ) : V it ( A it , K it ) = q t [ A it + γ K it ] log V it - log A it = Log Q it = log q t + γ K it / A it where Q is Tobin’s q , and γ is the relative shadow value of K May 18 , 2001 HJT - Oxford - May 2001 18 Hedonic regression for market value Practice ( 2 ) : ( without using log ( 1 + ε ) ! ε ) Log Q it = logq t + log ( 1 + γ t Kit / A it ) + ! t d ( K it = 0 ) where Q it = V it / A it ( market to book or Tobin’s Q ) Interpretation : ! t = Premium or discount for the absence of K assets . q t = overall market level ( approximately one ) . γ t = Relative shadow value of K assets ( = 1 if depreciation correct , investment strategy optimal , and no adjustment costs ) . 4 May 18 , 2001 HJT - Oxford - May 2001 19 1 . Basic results Year - by - year specification compares the different K measures ( Figure 4 ) – horse race . Exploration of the functional form using pooled data , constant coefficients ( Tables 2 , 3 , and 4 ) . Conclusion : R & D stock has the highest explanatory power for market value , but citation - weighted patent stocks are significantly more related to value than ordinary patent stocks May 18 , 2001 HJT - Oxford - May 2001 20 Period : 1976 - 1984 Number of observations R & D Stock / Assets 1 . 741 ( . 070 ) D ( R & D = 0 ) - - Patent Stock / Assets 0 . 493 ( . 042 ) Cite Stock / Assets 0 . 087 ( . 006 ) D ( Pats = 0 ) 0 . 252 ( . 019 ) 0 . 282 ( . 018 ) R - squared 0 . 249 0 . 127 0 . 161 Std . Err . 0 . 683 0 . 737 0 . 722 Ratio of Total Pats or Cites to Total R & D ( $ 1980M ) 0 . 550 4 . 125 Coefficient scaled by ratio of totals 1 . 741 0 . 271 0 . 359 Heteroskedastic - consistent standard errors . All equations have a complete set of year dummies . Stocks are computed using 15 percent annual depreciation rate . Citation stocks are patent stocks weighted by all the cites they received before 1994 plus an estimate o 10 , 761 Table 2 ( Excerpt ) “Horse Race” Regressions Comparing R & D , Patents , and Cites U . S . Manufacturing Firms that have R & D May 18 , 2001 HJT - Oxford - May 2001 21 Figure 5a R & D Performing Firms - R - Squared from Tobin ' s Q Equation 0 . 000 0 . 050 0 . 100 0 . 150 0 . 200 0 . 250 1973 1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 Year R - s qu a r e d R & D Stock / Assets Pat Stock / Assets Cite - wtd Pat Stock / Assets Past Cite - wtd Stock / Assets May 18 , 2001 HJT - Oxford - May 2001 22 2 . Exploration of cites variable Table 3 - include stock of R & D , patents per R & D , and cites per patent . Cites per patent are more important than patent yield itself : Increase of one cite per patent is associated with an increase of 3 - 4 % in market value Table 5 - break up cites per patent into five ranges : 0 to 4 , 4 to 6 , 6 to 10 , 10 to 20 , over 20 Only the latter three categories are positive ; the other two are zero – 50 - 75 % boost to market value if citations per patent average above 20 ! May 18 , 2001 HJT - Oxford - May 2001 23 Indep Variable K and C / P K , P / K , C / P P / A only R & D Stock ( K ) / Assets 0 . 961 ( . 041 ) 0 . 995 ( . 043 ) D ( R & D = 0 ) - - - - Pat Stock / A 0 . 520 ( . 039 ) Pat Stock / K 0 . 024 ( . 006 ) D ( Pats = 0 ) 0 . 246 ( . 022 ) 0 . 270 ( . 023 ) 0 . 460 ( . 024 ) 4 - 6 Cites per Patent ( 3 , 211 observations ) - . 019 ( . 022 ) - . 019 ( . 022 ) - . 058 ( . 023 ) 6 - 10 Cites per Patent ( 3 , 900 observations ) 0 . 085 ( . 021 ) 0 . 086 ( . 021 ) 0 . 081 ( . 022 ) 10 - 20 Cites per Patent ( 1 , 853 observations ) 0 . 357 ( . 027 ) 0 . 357 ( . 027 ) 0 . 456 ( . 028 ) > 20 Cites per Patent ( 508 observations ) 0 . 583 ( . 047 ) 0 . 590 ( . 047 ) 0 . 835 ( . 044 ) R - squared 0 . 245 0 . 249 0 . 180 Standard error 0 . 710 0 . 708 0 . 740 R & D - Doing Firms ( 12 , 771 obs ) Table 5 ( excerpt ) The Shape of the Citations - Value Relationship U . S . Manufacturing Firms 1979 - 88 May 18 , 2001 HJT - Oxford - May 2001 24 3 . Timing of the relationship Two separate cite - weighted patent stocks ! Pre and post the date of market value measure . Past stock is slightly negative in the presence of the total stock , which implies future citations are what matter . Orthogonal decomposition - unpredictable citations have a higher coefficient than predictable , both are positive . 5 May 18 , 2001 HJT - Oxford - May 2001 25 Independent Variable ( 1 ) ( 2 ) ( 3 ) Cite Stock / A 0 . 117 ( . 006 ) Past Cite Stk / A - 0 . 056 ( . 019 ) Future Cite Stk / A 0 . 162 ( . 008 ) Pred . Cite Stk / A 0 . 106 ( . 005 ) Unpred . Cite Stk / A 0 . 159 ( . 008 ) D ( P = 0 ) 0 . 204 ( . 012 ) 0 . 202 ( . 012 ) 0 . 202 ( . 012 ) R - squared 0 . 140 0 . 145 0 . 145 Standard error 0 . 740 0 . 737 0 . 737 Dep . Var . : logQ Table 4 ( excerpt ) Splitting Citation Stocks into Past and Future U . S . Manufacturing 1979 - 88 May 18 , 2001 HJT - Oxford - May 2001 26 4 . Self citations Self cites = citations to patents owned by the same firm . ! More valuable = > “owning” a technology trajectory , cumulativeness is valuable ! Less valuable = > cite whatever is at hand , does not necessarily signify any value Measures ! Share of citations that are self cites ! Self cites / patent – highly skew distribution ! Dummy for zero self cites May 18 , 2001 HJT - Oxford - May 2001 27 Self - citation share distribution Self - citation Share Distribution F r equen cy Dep . selfcite share 0 . 5 1 0 1000 2000 3000 4000 (cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0)(cid:0) May 18 , 2001 HJT - Oxford - May 2001 28 Table 6 ( excerpt ) Self - Citations and Market Value U . S . Manufacturing Firms 1979 - 88 Variable ( 1 ) ( 3 ) ( 4 ) K / Assets 1 . 203 ( . 056 ) * 1 . 385 ( . 078 ) * 1 . 081 ( . 069 ) * D ( K = 0 ) 0 . 017 ( . 017 ) 0 . 072 ( . 019 ) * 0 . 009 ( . 018 ) Pat stock / K 0 . 032 ( . 008 ) * 0 . 015 ( . 006 ) * Citations per patent 0 . 049 ( . 004 ) * 0 . 045 ( . 004 ) * Self citations per patent 0 . 058 ( . 015 ) * 0 . 104 ( . 017 ) * Log ( S ) = log ( sales ) - mean - . 0480 ( . 0059 ) * Log ( S ) * Self cites per patent - . 0258 ( . 0057 ) * D ( no self citations ) 0 . 161 ( . 051 ) * 0 . 127 ( . 047 ) * Log ( S ) * D ( no self ) - . 079 ( . 065 ) Chi - squared versus col . ( 1 ) 622 . 6 815 . 4 Degrees of freedom 4 7 Chi - squared per d . f . 155 . 7 116 . 5 12 , 030 Firm - years 1979 - 88 May 18 , 2001 HJT - Oxford - May 2001 29 Self - citation value and firm size - 0 . 60 - 0 . 40 - 0 . 20 0 . 00 0 . 20 0 . 40 0 . 60 0 . 80 1 . 00 1 . 20 0 . 00 0 . 01 0 . 10 1 . 00 10 . 00 100 . 00 1 , 000 . 00 10 , 000 . 00 100 , 000 . 00 1 , 000 , 000 . 0 0 Sales ( $ M ) S e l f - c i t es / p a t e n t C o e ff i c i e n t Dummy ( self = 0 ) Selfpat Coefficient May 18 , 2001 HJT - Oxford - May 2001 30 Answers to our questions 1 . Do the number of cites received by patents help to explain “value” in the presence of a . Patent counts themselves - yes b . R & D spending - yes 2 . What is the timing ? Is current market value better explained by past cites received or future cites not yet received ? - future cites 3 . Are self - citations more or less valuable than other citations ? - more valuable 6 May 18 , 2001 HJT - Oxford - May 2001 31 Questions for further work Controlling for field - citations and / or patents How far into the future does the market see citations ? Generality - is it worth more or less ? Does it depend on the firm ?